Devyser launches Devyser HLA Loss: A high-precision NGS assay for post-transplant research
Devyser, a pioneer in advanced genetic testing solutions, proudly announces the global launch of...
Devyser, a pioneer in advanced genetic testing solutions, proudly announces the global launch of...
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a significant...
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation...
Devyser a leading provider of genetic testing solutions, has been awarded a significant tender for...
Devyser has launched Devyser Thalassemia v2, a next-generation sequencing (NGS) solution designed...
Thalassemia and hemoglobinopathies are among the most common genetic disorders worldwide, affecting...
Hereditary cancers, particularly breast and ovarian cancers, pose a significant risk for many...